Home » Topics » Regulatory » Patents

Patents
RSS

New anticancer agents patented

Nov. 10, 2006

Novel agents for cardiovascular disorders disclosed in recent patents

Nov. 9, 2006

Recent Tibotec and Trimeris patents report novel agents for HIV infection

Nov. 9, 2006

Recent Elan, Xenon and Gruenenthal patents disclose novel analgesic agents

Nov. 9, 2006

Recent patents cover new therapeutic agents for cancer

Nov. 8, 2006

Recent patents describe new antidiabetic agents

Nov. 8, 2006

Recent Dabur patent describes novel peptide-based therapeutic agents for alopecia

Nov. 8, 2006

Novel immunosuppressant agents disclosed by Pharmacopeia

Nov. 7, 2006

Recent Novo Nordisk and Roche patents disclose novel treatment strategies for obesity

Nov. 7, 2006

Recent patents report new therapeutic agents for anxiety, depression, sleep disorders, etc.

Nov. 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...